COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

Aidan Gonzalvez Killed in Crash at Chestnut and American Avenues


2-Year-Old Dies in Fatal Hit and Run Accident in Fresno

Fresno, CA (May 12, 2020) – A 2-year-old boy was killed in a pedestrian crash in Fresno. The fatal accident occurred on the evening of May 12 at Chestnut and American avenues.

Aidan Gonzalvez ran outside the door of his home. His mother ran to grab him, but he was hit by a vehicle. The driver kept going. The 2-year-old boy died in the crash.

CHP located a passenger van in connection with the accident. Authorities are processing that vehicle for DNA and the driver is cooperating. 

Our heartfelt condolences go out to the friends and loved ones of Aidan Gonzalvez. 

#Fresno

#93725


March 31, 2020

Man Killed in Crash on South Avenue

Ford T-Bones Honda in Fatal Fresno Accident...


May 20, 2020

1 Injured in Crash at Terreno Drive and De Luz Road

Head-on Accident in Temecula Causes Major Injuries...


September 9, 2020

2 Killed in Crash on Interstate 5 Near Lenahan Road

Motorcycle Hits Fence in Fatal Williams Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.